Literature DB >> 3542066

Gluconeogenesis in late fetal and early neonatal life.

J Girard.   

Abstract

Birth in most mammalian species represents an abrupt change from a high-carbohydrate and low-fat diet to a high-fat and low-carbohydrate diet. Gluconeogenesis is absent from the liver of the fetus of well fed mothers, but can be induced prematurely by prolonged fasting of the mother. Gluconeogenesis increases rapidly in the liver of newborn mammals in parallel with the appearance of phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme of this pathway. The rise in plasma glucagon and the fall in plasma insulin which occur immediately after birth are the main determinants of liver PEPCK induction. When liver PEPCK has reached its adult value, i.e. 24 h after birth, other factors are involved in the regulation of hepatic gluconeogensis. In order to maintain a high gluconeogenic rate, the newborn liver must be supplied with sufficient amount of gluconeogenic substrates and free fatty acids. An active hepatic fatty acid oxidation is necessary to support hepatic gluconeogenesis by providing essential cofactors such as acetyl CoA and NADH. The relevance of animal studies for the understanding of neonatal glucose homeostasis in man is discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3542066     DOI: 10.1159/000242605

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  21 in total

1.  Evolution of pyruvate carboxylase and other biotin containing enzymes in developing rat liver and kidney.

Authors:  R Salto; M D Girón; M del Mar Sola; A M Vargas
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

2.  Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice.

Authors:  M K Short; D E Clouthier; I M Schaefer; R E Hammer; M A Magnuson; E G Beale
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 3.  Intrauterine Growth Restriction: Hungry for an Answer.

Authors:  Sherin U Devaskar; Alison Chu
Journal:  Physiology (Bethesda)       Date:  2016-03

4.  Sustained hypoxemia in late gestation potentiates hepatic gluconeogenic gene expression but does not activate glucose production in the ovine fetus.

Authors:  Amanda K Jones; Paul J Rozance; Laura D Brown; David A Goldstrohm; William W Hay; Sean W Limesand; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

Review 5.  Neonatal nutrition: a brief review.

Authors:  David L Schutzman; Rachel Porat; Agnes Salvador; Michael Janeczko
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

6.  Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

Authors:  Popi Sifianou; Voula Thanou; Helen Karga
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

7.  Early onset of fatty liver in growth-restricted rat fetuses and newborns.

Authors:  Makiko Yamada; Diana Wolfe; Guang Han; Samuel W French; Michael G Ross; Mina Desai
Journal:  Congenit Anom (Kyoto)       Date:  2011-12       Impact factor: 1.409

8.  Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates.

Authors:  Carrie E McCurdy; Jacalyn M Bishop; Sarah M Williams; Bernadette E Grayson; M Susan Smith; Jacob E Friedman; Kevin L Grove
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

9.  Effects of chronic hyperinsulinemia on metabolic pathways and insulin signaling in the fetal liver.

Authors:  Paul J Rozance; Amanda K Jones; Stephanie L Bourque; Angelo D'Alessandro; William W Hay; Laura D Brown; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-24       Impact factor: 4.310

10.  The role of pancreatic insulin secretion in neonatal glucoregulation. II. Infants with disordered blood glucose homoeostasis.

Authors:  J M Hawdon; A Aynsley-Green; K Bartlett; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.